Published in COPD on February 01, 2008
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. PLoS One (2010) 1.26
Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis (2010) 1.19
Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest (2014) 1.00
Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes. J Allergy Clin Immunol (2012) 1.00
Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun (2010) 0.99
(1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients. Eur J Clin Microbiol Infect Dis (2014) 0.95
Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease. Immunol Res (2011) 0.93
Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells. MBio (2014) 0.91
Analysis of current antifungal agents and their targets within the Pneumocystis carinii genome. Curr Drug Targets (2012) 0.87
Factors associated with abnormal spirometry among HIV-infected individuals. AIDS (2015) 0.87
Pneumocystis jirovecii colonization in chronic pulmonary disease. Parasite (2011) 0.86
B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice. J Immunol (2015) 0.86
Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects. Respir Res (2011) 0.85
Molecular detection of pneumocystis jirovecii in patients with respiratory tract infections. N Am J Med Sci (2012) 0.85
Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice. PLoS One (2013) 0.82
Pneumocystis workshop: 10th anniversary summary. Eukaryot Cell (2009) 0.81
MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection. J Immunol (2013) 0.80
Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. Am J Pathol (2012) 0.79
A new method for the detection of Pneumocystis jirovecii using flow cytometry. Eur J Clin Microbiol Infect Dis (2010) 0.77
Fungal colonization with Pneumocystis correlates to increasing chloride channel accessory 1 (hCLCA1) suggesting a pathway for up-regulation of airway mucus responses, in infant lungs. Results Immunol (2014) 0.77
Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD. PLoS One (2015) 0.77
Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease. Front Microbiol (2017) 0.76
Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection. J Acquir Immune Defic Syndr (2014) 0.76
Functional Characterization of Pneumocystis carinii Inositol Transporter 1. MBio (2016) 0.75
The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities. Eukaryot Cell (2011) 0.75
Pneumocystis infection alters the activation state of pulmonary macrophages. Immunobiology (2016) 0.75
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. PLoS One (2017) 0.75
Circulating genotypes of Pneumocystis jirovecii and its clinical correlation in patients from a single tertiary center in India. Eur J Clin Microbiol Infect Dis (2017) 0.75
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J (2003) 6.23
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature (1988) 5.21
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics (1978) 4.44
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax (2002) 4.26
Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med (2001) 4.25
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2006) 4.11
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 3.69
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med (1997) 3.20
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med (2004) 3.12
The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis (1992) 3.01
Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis (1977) 2.90
Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis (1982) 2.80
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med (2000) 2.77
Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med (1998) 2.62
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 2.52
Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J (1999) 2.44
Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin. Mol Biochem Parasitol (1990) 2.42
Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax (2003) 2.33
Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med (1992) 2.27
Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med (2004) 2.05
A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol (1992) 1.92
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91
Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol (2001) 1.88
Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.85
Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol (1996) 1.71
Infectious etiology of acute exacerbations of chronic bronchitis. Chest (2000) 1.63
Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol (1999) 1.58
Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56
Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax (1988) 1.56
Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax (2003) 1.54
Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS (2004) 1.54
Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J (1998) 1.50
Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis (1992) 1.48
Bacterial infection and the pathogenesis of COPD. Chest (2000) 1.47
Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol (1993) 1.43
Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene (2000) 1.38
Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet (1996) 1.37
Pneumocystis carinii: what is it, exactly? Clin Microbiol Rev (1996) 1.33
Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease. Clin Exp Immunol (2006) 1.31
Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun (2003) 1.30
Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc (2004) 1.27
New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease. Thorax (1993) 1.23
An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study. Respir Res (2006) 1.22
Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol (2002) 1.20
Infection with Pneumocystis carinii is prevalent in healthy Gambian children. Trans R Soc Trop Med Hyg (1991) 1.17
Detection of Pneumocystis carinii DNA in patients with chronic lung diseases. Eur J Clin Microbiol Infect Dis (2000) 1.16
DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms. Respir Med (1993) 1.07
Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am J Respir Cell Mol Biol (1997) 1.07
Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin Infect Dis (1999) 1.06
Pneumocystis colonization in HIV-infected patients. J Eukaryot Microbiol (2003) 1.06
Characterization of T lymphocytes in chronic obstructive pulmonary disease. PLoS Med (2004) 1.05
Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol Res (2006) 1.05
Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J Infect Dis (2003) 1.05
The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur Respir J (1998) 1.04
A Pneumocystis carinii multi-gene family with homology to subtilisin-like serine proteases. Microbiology (1997) 1.03
Cardiorespiratory adaptation during sleep in infants and children. Pediatr Pulmonol (1995) 1.03
Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection. Infect Immun (1992) 1.01
Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J Infect (2006) 0.99
Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis (2004) 0.98
Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest (2000) 0.95
Altered T-cell phenotypes in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.94
A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci. Infect Immun (2003) 0.93
Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by human immunodeficiency virus. J Clin Microbiol (1995) 0.91
Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study. BMC Infect Dis (2002) 0.91
Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections. Eur J Clin Microbiol Infect Dis (2001) 0.90
Collagenases and the serine proteinases elastase and cathepsin G in steroid-induced Pneumocystis carinii pneumonia. J Clin Microbiol (1995) 0.89
Immune responses to Pneumocystis colonization and infection in a simian model of AIDS. J Eukaryot Microbiol (2003) 0.87
The fungal nature of Pneumocystis. J Med Vet Mycol (1992) 0.86
Bronchial inflammation: its relationship to colonizing microbial load and alpha(1)-antitrypsin deficiency. Chest (2000) 0.85
Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease. Clin Exp Allergy (2001) 0.82
Relationship between the burden of Pneumocystis carinii, the inflammatory reaction and lung injury in Pneumocystis carinii pneumonia. Chin Med J (Engl) (2000) 0.82
Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase inhibitors in vitro. Parasite (1999) 0.80
Natural transmission of Pneumocystis carinii in nonimmunosuppressed animals: early contagiousness of experimentally infected rabbits (Oryctolagus cuniculus). J Clin Microbiol (1997) 0.78
Detection of Pneumocystis carinii in oropharyngeal washings by PCR-SHELA and nested PCR. J Eukaryot Microbiol (1998) 0.78
Lymphocyte response in subjects with chronic pulmonary disease colonized by Pneumocystis jirovecii. J Eukaryot Microbiol (2003) 0.78
Small airways dysfunction in patients with AIDS and Pneumocystis carinii pneumonia. AIDS Patient Care STDS (1996) 0.77
Chronic obstructive pulmonary disease. Clin Evid (2006) 0.76
The Lung Health Study. Baseline characteristics of randomized participants. Chest (1993) 0.76
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med (2011) 4.75
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med (2008) 3.94
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med (2011) 3.33
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol (2013) 2.60
Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med (2010) 2.60
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg (2006) 2.53
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42
Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest (2005) 2.15
The relationship between pulmonary emphysema and kidney function in smokers. Chest (2012) 2.13
Automated lung segmentation in X-ray computed tomography: development and evaluation of a heuristic threshold-based scheme. Acad Radiol (2003) 2.10
Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med (2004) 2.05
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.98
Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med (2007) 1.94
Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.94
Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med (2010) 1.81
CT metrics of airway disease and emphysema in severe COPD. Chest (2009) 1.81
Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med (2012) 1.80
Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses. Am J Respir Crit Care Med (2013) 1.77
Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One (2009) 1.71
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev (2012) 1.68
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2007) 1.68
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67
Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol (2009) 1.63
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.63
Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study. J Thorac Oncol (2011) 1.57
Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS (2004) 1.54
Activity monitoring and energy expenditure in COPD patients: a validation study. COPD (2007) 1.54
Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax (2014) 1.48
Feasibility of retinoids for the treatment of emphysema study. Chest (2006) 1.45
Clinical significance of radiologic characterizations in COPD. COPD (2009) 1.41
Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD (2008) 1.38
Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease. J Immunol (2009) 1.34
Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PLoS One (2012) 1.30
The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One (2009) 1.28
Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol (2009) 1.20
A Computational geometry approach to automated pulmonary fissure segmentation in CT examinations. IEEE Trans Med Imaging (2008) 1.20
Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis (2010) 1.19
Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. AIDS (2012) 1.18
Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials. Am J Respir Crit Care Med (2006) 1.14
Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J Allergy Clin Immunol (2011) 1.13
Optimal threshold in CT quantification of emphysema. Eur Radiol (2012) 1.12
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res (2010) 1.07
Missing value imputation in high-dimensional phenomic data: imputable or not, and how? BMC Bioinformatics (2014) 1.06
A differential geometric approach to automated segmentation of human airway tree. IEEE Trans Med Imaging (2010) 1.05
Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J Infect Dis (2003) 1.05
Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients. J Immunol (2013) 1.05
Physiological and computed tomographic predictors of outcome from lung volume reduction surgery. Am J Respir Crit Care Med (2009) 1.04
Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res (2007) 1.03
C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.03
The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis. PLoS One (2011) 1.02
Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res (2009) 1.00
Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). J Biol Chem (2013) 1.00
Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res (2013) 1.00
Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema. PLoS One (2013) 1.00
Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun (2010) 0.99
Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques. J Infect Dis (2009) 0.99
Automated detection and quantitative assessment of pulmonary airways depicted on CT images. Med Phys (2007) 0.99
Relationship of pneumocystis antibody response to severity of chronic obstructive pulmonary disease. Clin Infect Dis (2008) 0.97
Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2012) 0.97
Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med (2007) 0.96
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med (2011) 0.96
Exercise testing in severe emphysema: association with quality of life and lung function. COPD (2008) 0.96
Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques. AIDS Res Hum Retroviruses (2010) 0.95
Altered T-cell phenotypes in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 0.94
Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia. J Acquir Immune Defic Syndr (2011) 0.94
Assessment of lung volume collapsibility in chronic obstructive lung disease patients using CT. Eur Radiol (2013) 0.94
Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. Hum Mutat (2012) 0.93
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med (2014) 0.93
A new perspective on optimal care for patients with COPD. Prim Care Respir J (2011) 0.92
Trypanosoma cruzi recombinant complement regulatory protein: a novel antigen for use in an enzyme-linked immunosorbent assay for diagnosis of Chagas' disease. J Clin Microbiol (2002) 0.92
Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort. AIDS (2014) 0.91
Distribution of Pneumocystis jirovecii in lungs from colonized COPD patients. Diagn Microbiol Infect Dis (2011) 0.91
Exercise maintenance following pulmonary rehabilitation: effect of distractive stimuli. Chest (2002) 0.90
Plasma inflammatory mediators associated with bone metabolism in COPD. COPD (2010) 0.89
Alterations in T lymphocyte profiles of bronchoalveolar lavage fluid from SIV- and Pneumocystis carinii-coinfected rhesus macaques. AIDS Res Hum Retroviruses (2002) 0.89
Perfusion scintigraphy and patient selection for lung volume reduction surgery. Am J Respir Crit Care Med (2010) 0.89
Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med (2009) 0.88
Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function. J Acquir Immune Defic Syndr (2012) 0.88
Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. PLoS Negl Trop Dis (2010) 0.88
Immune responses to Pneumocystis colonization and infection in a simian model of AIDS. J Eukaryot Microbiol (2003) 0.87
Oxygen consumption, shuttle walking test and the evaluation of lung resection. Respiration (2009) 0.87
Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients. J Clin Microbiol (2004) 0.87
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest (2012) 0.86
Optimal protocol selection for cardiopulmonary exercise testing in severe COPD. Chest (2007) 0.86
Optimizing the 6-min walk test as a measure of exercise capacity in COPD. Chest (2012) 0.86